Carmot Therapeutics
Berkeley
About Carmot Therapeutics
Carmot Therapeutics provides drugs to treat inflammatory, metabolic, and neurological diseases. They employ their patented technology, chemotype evolution, to address the fundamental causes of disease and speed the discovery of disease-modifying therapies.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $384.8M
- Funding stage: M&A
- Last round: Series E (May 2023)
- Website: carmot.us
- Phone: 5105279251
Industries & Categories
Biotechnology, Health Care, Neuroscience, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/carmot-therapeutics-124570 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.